Skip to content
PlaySpot

Zimbabwe Turns Down ‘Unbalanced’ American Healthcare Assistance Deal Over Data Concerns

Medical aid illustration
The offered US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a major US healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' request for confidential information.

This move came to light following a government memo dated December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "skewed".

An official spokesman has since stated that the US was requesting biological samples for scientific study and commercial gain but was not willing to share the benefits from any future treatments.

"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has urged further negotiations to reach a deal suitable to both sides so the country's vital HIV programme can be sustained.

Broader Implications

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court halted a related health funding agreement following concerns were filed about the safety of citizens' health data.

Since returning to office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and accountability.

According to statements, Sixteen nations in Africa have so far agreed to these new health pacts, representing over $18.3bn in committed funds.

Details of the Rejected Deal

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this collaboration would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"Our nation was requested to provide its genetic material and health information indefinitely, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"In essence, our nation would provide the basic resources for medical research with no assurance that the final treatments would be available to our citizens if a new health crisis arise."

National Interest and International Frameworks

He also pointed out that the American exit from the global health body and its push of bilateral deals were undermining systems previously established through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.

"This system is designed to ensure that when a nation contributes its data, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We encourage ongoing dialogue with our US partners on how future co-operation could be designed in a way that respects the independence and interests of each country."

Medical Community Response

A leading public health body said it recognised the official position, but urged that negotiations need to persist since much of the nation's Aids initiatives depended on external financing.

"Where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group added.

This impasse underscores the complex challenges between receiving crucial foreign assistance and safeguarding a country's data in an ever more data-driven world.

Written by

Joseph Gardner

A passionate gamer and entertainment journalist with over a decade of experience covering industry trends and cultural phenomena.

PlaySpot

Type to search articles.